Literature DB >> 23093883

Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature.

Warren Allan Kaplan1, Lindsay Sarah Ritz, Marie Vitello.   

Abstract

OBJECTIVES: The objective of this study was to assess the existing theoretical and empirical literature examining the link between "local production" of pharmaceuticals and medical devices and increased local access to these products. Our preliminary hypothesis is that studies showing a robust relationship between local production and access to medical products are sparse, at best.
METHODS: An extensive literature search was conducted using a wide variety of databases and search terms intending to capture as many different aspects of this issue as possible. The results of the search were reviewed and categorized according to their relevance to the research question. The literature was also reviewed to determine the rigor used to examine the effects of local production and what implications these experiences hold for other developing countries.
RESULTS: Literature addressing the benefits of local production and the link between it and access to medical products is sparse, mainly descriptive and lacking empirical evidence. Of the literature we reviewed that addressed comparative economics and strategic planning of multinational and domestic firms, there are few dealing with emerging markets and lower-middle income countries and even fewer that compare local biomedical producers with multinational corporations in terms of a reasonable metric. What comparisons exist mainly relate to prices of local versus foreign/multinational produced medicines.
CONCLUSIONS: An assessment of the existing theoretical and empirical literature examining the link between "local production" of pharmaceuticals and medical devices and increased local access to these products reveals a paucity of literature explicitly dealing with this issue. Of the literature that does exist, methods used to date are insufficient to prove a robust relationship between local production of medical products and access to these products. There are mixed messages from various studies, and although the studies may correctly depict specific situations in specific countries with reference to specific products, such evidence cannot be generalized. Our review strongly supports the need for further research in understanding the dynamic link between local production and access to medical products.

Entities:  

Keywords:  Access to Medicines; Industrial Policy; Pharmaceutical Policy; Pharmaceuticals

Year:  2011        PMID: 23093883      PMCID: PMC3471180          DOI: 10.5655/smr.v4i2.1002

Source DB:  PubMed          Journal:  South Med Rev        ISSN: 1174-2704


  11 in total

1.  Access to antiretroviral drugs in Brazil.

Authors:  Jane Galvão
Journal:  Lancet       Date:  2002-12-07       Impact factor: 79.321

2.  Influence of manufacturing practices on quality of pharmaceutical products manufactured in Kenya.

Authors:  J A Orwa; L K Keter; S P A Ouko; I O Kibwage; G M Rukunga
Journal:  East Afr Med J       Date:  2004-06

3.  Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India.

Authors:  Shubham Chaudhuri; Pinelopi K Goldberg; Panle Jia
Journal:  Am Econ Rev       Date:  2006-12

4.  Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

Authors:  Stephen B Soumerai; Fang Zhang; Dennis Ross-Degnan; Daniel E Ball; Robert F LeCates; Michael R Law; Tom E Hughes; Daniel Chapman; Alyce S Adams
Journal:  Health Aff (Millwood)       Date:  2008-04-01       Impact factor: 6.301

5.  Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.

Authors:  Maaike S M van Mourik; Alexandra Cameron; Marg Ewen; Richard O Laing
Journal:  BMC Cardiovasc Disord       Date:  2010-06-09       Impact factor: 2.298

6.  Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world.

Authors:  Laurens M Niëns; Alexandra Cameron; Ellen Van de Poel; Margaret Ewen; Werner B F Brouwer; Richard Laing
Journal:  PLoS Med       Date:  2010-08-31       Impact factor: 11.069

7.  Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.

Authors:  A Cameron; M Ewen; D Ross-Degnan; D Ball; R Laing
Journal:  Lancet       Date:  2008-11-29       Impact factor: 79.321

8.  Availability, price and affordability of asthma medicines in five Indian states.

Authors:  A Kotwani
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

9.  Methods for estimating confidence intervals in interrupted time series analyses of health interventions.

Authors:  Fang Zhang; Anita K Wagner; Stephen B Soumerai; Dennis Ross-Degnan
Journal:  J Clin Epidemiol       Date:  2008-11-17       Impact factor: 6.437

Review 10.  Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.

Authors:  Nathan Ford; David Wilson; Gabriela Costa Chaves; Michel Lotrowska; Kannikar Kijtiwatchakul
Journal:  AIDS       Date:  2007-07       Impact factor: 4.177

View more
  13 in total

1.  Responding to maternal, neonatal and child health equipment needs in Kenya: a model for an innovation ecosystem leveraging on collaborations and partnerships.

Authors:  Richard Ayah; John Ong'ech; Edwin Maina Mbugua; Rose Chepchumba Kosgei; Katie Waller; David Gathara
Journal:  BMJ Innov       Date:  2020-04-24

2.  Registration and local production of essential medicines in Uganda.

Authors:  Petra Brhlikova; Karen Maigetter; Jude Murison; Amon G Agaba; Jonans Tusiimire; Allyson M Pollock
Journal:  J Pharm Policy Pract       Date:  2020-08-11

3.  Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal.

Authors:  Petra Brhlikova; Ian Harper; Madhusudan Subedi; Samita Bhattarai; Nabin Rawal; Allyson M Pollock
Journal:  Global Health       Date:  2015-06-14       Impact factor: 4.185

4.  Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania.

Authors:  M Ewen; W Kaplan; T Gedif; M Justin-Temu; C Vialle-Valentin; Z Mirza; B Regeer; M Zweekhorst; R Laing
Journal:  J Pharm Policy Pract       Date:  2017-01-16

Review 5.  Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand.

Authors:  Sochea Phok; Saysana Phanalasy; Si Thu Thein; Asawin Likhitsup
Journal:  Malar J       Date:  2017-05-02       Impact factor: 2.979

6.  Health-industry linkages for local health: reframing policies for African health system strengthening.

Authors:  Maureen Mackintosh; Julius Mugwagwa; Geoffrey Banda; Paula Tibandebage; Jires Tunguhole; Samuel Wangwe; Mercy Karimi Njeru
Journal:  Health Policy Plan       Date:  2018-05-01       Impact factor: 3.344

7.  3D-printed activated charcoal inlet filters for oxygen concentrators: A circular economy approach.

Authors:  Ellis Williams; Davide Piaggio; Martina Andellini; Leandro Pecchia
Journal:  Dev Eng       Date:  2022-01-19

8.  Essential medicines are more available than other medicines around the globe.

Authors:  Yaser T Bazargani; Margaret Ewen; Anthonius de Boer; Hubert G M Leufkens; Aukje K Mantel-Teeuwisse
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

9.  Selecting an appropriate strategy to make quality 7.1 % chlorhexidine digluconate accessible for umbilical cord care.

Authors:  Mutsumi Metzler; Patricia S Coffey
Journal:  J Pharm Policy Pract       Date:  2016-04-08

10.  Gap analysis for drug development policy-making: An attempt to close the gap between policy and its implementation.

Authors:  Ria Christine Siagian; Dumilah Ayuningtyas
Journal:  PLoS One       Date:  2019-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.